Dergiler / Eurasian Journal of Medical Investigation / 2021 / Cilt: 5 - Sayı: 4

The Impact of COVID-19 on Anxiety Levels of Cancer Patients

Sayfa
448–453
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this regard, the rates of anxiety level during the pandemic period in this patient group were found to be higher than the rates in the studies conducted before pandemic period.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Coronavirus 2019 disease (COVID-19) has caused serious anxiety and fear around the world.
📊
Temel Bulgular & Veri:Methods: In this study, HADS (Hospital Anxiety and Depression Scale) and STAI 1-2 scales (State-Trait Anxiety Inven- tory) were applied for psychological evaluation through a questionnaire to help learning opinions on COVID-19 of 180 patients who were included in consecutively and whose follow-up and treatment continue at university hospital of oncology unit.
💡
Sonuç & Katkı:In this regard, the rates of anxiety level during the pandemic period in this patient group were found to be higher than the rates in the studies conducted before pandemic period.
🔬Tür:Uygulamalı Anket & Alan Araştırması
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: Coronavirus 2019 disease (COVID-19) has caused serious anxiety and fear around the world. Anxiety level may be higher in risky and chronic groups such as cancer patients. In our study, it was aimed to evaluate the factors becoming potentially effective on the anxiety status and levels of cancer patients during the pandemic by means of questionnaires and psychiatric scales. Methods: In this study, HADS (Hospital Anxiety and Depression Scale) and STAI 1-2 scales (State-Trait Anxiety Inven- tory) were applied for psychological evaluation through a questionnaire to help learning opinions on COVID-19 of 180 patients who were included in consecutively and whose follow-up and treatment continue at university hospital of oncology unit. Results: In the study, it draws attention that more than half of the patients have a fear related to COVID-19. Median hads anxiety score of the patients was found as; 6 (0-18), depression score; 6 (0-17), median STAI-1 score; 38 (25-65), median STAI-2 score; 43 (23-74). In multivariate analysis, the followings were found as the independent risk factors related to the fear of COVID-19; female gender, high anxiety and STAI-2 scores as well as psychiatric disease presence in family and old age. Conclusion: It is known that increased anxiety levels are observed in normal times in cancer patients. In this regard, the rates of anxiety level during the pandemic period in this patient group were found to be higher than the rates in the studies conducted before pandemic period.

🔖

Bu Makaleye Atıf Yap

Ersoy, M., Demir, N., Uzun, M. E., Yildiz, B., Garbioglu, D. B., Garbioglu, A., Dincer, M. (2022). The Impact of COVID-19 on Anxiety Levels of Cancer Patients. Eurasian Journal of Medical Investigation, Cilt: 5 - Sayı: 4, 448–453. https://ajindex.com/articles/508568

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. WHO. Coronavirus disease (COVID-19): Weekly epidemio - logical update. Available at: https://https://www.who.int/ publications/m/item/weekly-epidemiological-update- --13-May-2021. Accessed May 13, 2021
  2. Lin CY. Social reaction toward the 2019 novel coronavirus (CO- VID-19). J Soc Health Behav 2020;3:1–2
  3. Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther 2020;14:58–60
  4. Lee AM, Wong JG, McAlonan GM, Cheung V, Cheung C, Sham PC, et al. Stress and psychological distress among SARS survi- vors 1 year after the outbreak. Can J Psychiatry 2007;52:233-40
  5. Lai AG, Pasea L, Banerjee A, Denaxas S, Katsoulis M, Chang WH, et al. Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency. MedRxiv Jun 01, 2020, doi: 10.1101/2020.05.27.20083287. [Epub ahead of print]
  6. Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19- infected cancer patients: A retro- spective case study in three hospitals within Wuhan, China. Ann Oncol 2020;31:894–901
  7. Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol 2020;21:629–30
  8. Ürün Y, Hussain SA, Bakouny Z, Castellano D, Kılıçkap S, Mor- gan G, et al. Survey of the impact of COVID-19 on oncologists' decision making in cancer. JCO Glob Oncol 2020;6:1248–57
  9. Greer JA, Pirl WF, Park ER, Lynch TJ, Temel JS. Behavioral and psychological predictors of chemotherapy adherence in pa- tients with advanced non-small cell lung cancer. J Psychosom Res 2008;65:549–52
  10. Zigmund AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361–70
  11. Julian LJ. Measures of anxiety: State-Trait anxiety inventory (STAI), beck anxiety inventory (BAI), and hospital anxiety and depression Scale-Anxiety (HADS-A). Arthritis Care Res 2011;63:467–72
  12. The global cancer observatory. Number in 2020, both sexes, all ages. Available at: https://gco.iarc.fr/today/data/fact- sheets/populations/900-world-fact-sheets.pdf. Accessed Feb 2, 2021
  13. Sigorski D, Sobczuk P, Osmola M, Kuć K, Walerzak A, Wilk M, et al. Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy. ESMO Open 2020;5:e000970
  14. Musche V, Bäuerle A, Steinbach J, Schweda A, Hetkamp M, Weismüller B, et al. COVID-19-related fear and health-relat- ed safety behavior in oncological patients. Front Psychol 2020;11:1984
  15. Fossa SD. Dahl AA. Short form 36 and hos